Acquired psychiatric disorder decisions — 2025

The Board granted an effective date of August 12, 2021, for the award of service connection for an acquired psychiatric disorder.

The Board granted service connection for tinnitus, but remanded the claims for service connection for an acquired psychiatric disorder, a left ankle disability, and a neck disability.

The Board remands the claims for service connection for various disabilities to allow for further development, including obtaining outstanding medical records and scheduling VA examinations.

The Board denied the veteran's claims for an earlier effective date, increased ratings, and TDIU, but granted a total disability rating based on individual unemployability beginning September 29, 2023.

The Board granted service connection for obstructive sleep apnea (OSA) but denied service connection for sleep disturbances as a separate disability and denied an evaluation in excess of 50 percent for the Veteran's acquired psychiatric disability.

The Board denied service connection for various conditions and a compensable disability rating for the Veteran's trochanteric pain syndrome with limitation of flexion of the right thigh, as well as migraines including migraine variants.

The Board granted an initial rating of 70 percent, but no higher, for the Veteran's acquired psychiatric disorder based on the severity and frequency of symptoms that caused occupational and social impairment with deficiencies in most areas.

The Board granted service connection for prostate cancer, acquired psychiatric condition (depression), and erectile dysfunction based on the Veteran's in-service exposure to contaminated water at Camp Lejeune.

The Board granted service connection for an acquired psychiatric disorder, other than depression, anxiety, and insomnia disorders, to include PTSD.

The Board denied service connection for diabetes mellitus and an eye disability, but granted service connection for a depressive disorder and stressor disorder.

The appeal for service connection for an acquired psychiatric disorder was dismissed as the issue is now moot due to a full grant of benefits.

The Board denied the Veteran's claim for service connection for a psychiatric disorder, to include bipolar disorder, as there was no evidence of a mental health disorder during or related to active service.

The Board granted service connection for an acquired psychiatric disorder, to include unspecified depressive and anxiety disorders, finding the evidence is at least evenly balanced as to whether it is related to the Veteran's active-duty service.

The Board remands all issues on appeal for further development, including obtaining additional medical opinions and ensuring compliance with prior remand directives.

The Board denied the Veteran's request for an effective date earlier than January 22, 1999, for service connection for schizophrenia. The Board found that the Veteran's September 1975 statement did not constitute a valid Notice of Disagreement and therefore the September 1975 administrative decision became final, precluding an earlier effective date.

The Board remands the claims for service connection for migraine headaches and an acquired psychiatric disorder to include adjustment disorder with anxiety and dressed mood due to inadequate medical opinions.

The Board granted a 50 percent disability rating for the acquired psychiatric disorder from June 4, 2010 to June 29, 2014.

The Board denied a rating in excess of 10 percent for bilateral tinnitus, granted an initial 30 percent rating for the acquired psychiatric disability prior to April 22, 2019 and a 50 percent rating from April 22, 2019 to December 26, 2019, but denied a rating in excess of 50 percent thereafter. The Board also denied a rating in excess of 30 percent for ischemic heart disease.

The Board denied service connection for bilateral hearing loss and tinnitus, and remanded claims for an acquired psychiatric disorder, a bilateral foot disability, and a bilateral knee disability.

The Board dismissed the appeal for service connection for bilateral hearing loss and tinnitus due to a concurrent pending Higher-Level Review request.